Federal Register / Vol. 86, No. 159 / Friday, August 20, 2021 / Notices 46859 

License applications submitted in 

response to this Notice will be 

presumed to contain business 

confidential information and any release 

of information in these license 

applications will be made only as 

required and upon a request under the 

Freedom of Information Act, 5 U.S.C. 

552. 

Dated: August 16, 2021. 

Richard U. Rodriguez, 

Associate Director, Technology Transfer 

Center, National Cancer Institute. 

[FR Doc. 2021–17849 Filed 8–19–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; 

Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Diabetes and 

Digestive and Kidney Diseases Advisory 

Council, September 09, 2021, 10:00 a.m. 

to September 10, 2021, 12:45 p.m., 

National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD, 20892 which 

was published in the Federal Register 

on August 09, 2021, FR Doc 2021– 

16952, 86 FR 43557. 

The meeting notice is amended to 

change and adjust the Opening and 

Closing times on the Subcommittees 

and Executive Sessions. The meeting is 

partially Closed to the public. 

Dated: August 17, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–17876 Filed 8–19–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel; AMP AIM 

Technology and Analytic Cores Review. 

Date: September 15, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Arthritis and 

Musculoskeletal and Skin Diseases, 6701 

Democracy Blvd, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Kan Ma, Ph.D., Scientific 

Review Officer, Scientific Review Branch, 

National Institute of Arthritis, 

Musculoskeletal and Skin Diseases, NIH, 

6701 Democracy Boulevard, Suite 814, 

Bethesda, MD 20892, 301–451–4838, mak2@

mail.nih.gov. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel; AMP–AIM 

Disease Team Review. 

Date: September 17, 2021. 

Time: 10:30 a.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Arthritis and 

Musculoskeletal and Skin Diseases, 6701 

Democracy Blvd., Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Yin Liu, Ph.D., MD 

Scientific Review Officer, Scientific Review 

Branch, National Institute of Arthritis, and 

Musculoskeletal and Skin Diseases, National 

Institute of Health, Bethesda, MD 20892, 

301–496–0505 liuy@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS) 

Dated: August 17, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–17873 Filed 8–19–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Council of Councils. 

The meeting will be held as a virtual 

meeting and will be open to the public 

as indicated below. Individuals who 

plan to view the virtual meeting and 

need special assistance or other 

reasonable accommodations to view the 

meeting, should notify the Contact 

Person listed below in advance of the 

meeting. The open sessions will be 

videocast and can be accessed from the 

NIH Videocasting and Podcasting 

website (http://videocast.nih.gov). 

A portion of the meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4), and 552b(c)(6), Title 5 

U.S.C., as amended. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Council of Councils. 

Open: September 17, 2021. 

Time: 10:00 a.m. to 12:10 p.m. 

Agenda: Call to Order and Introductions; 

Announcements and Updates; NIH Program 

Updates; Scientific Talks and Other Business 

of the Committee. 

Place: National Institutes of Health, 

Building 1, One Center Drive, Bethesda, MD 

20892 (Virtual Meeting). 

Name of Committee: Council of Councils. 

Closed: September 17, 2021. 

Time: 12:10 p.m. to 1:10 p.m. 

Agenda: Review of Grant Applications. 

Place: National Institutes of Health, 

Building 1, One Center Drive, Bethesda, MD 

20892 (Virtual Meeting). 

Open: September 17, 2021. 

Time: 1:30 p.m. to 5:10 p.m. 

Agenda: NIH Program Updates; Scientific 

Talks and Other Business of the Committee. 

Place: National Institutes of Health, 

Building 1, One Center Drive, Bethesda, MD 

20892 (Virtual Meeting). 

Contact Person: Robert W. Eisinger, Ph.D., 

Executive Secretary, Council of Councils, 

Senior Scientific Advisor, Division of 

Program Coordination, Planning, and 

Strategic Initiatives, Office of the Director, 

NIH, Building 1, Room 258, One Center 

Drive, Bethesda, MD 20892, robert.eisinger@

nih.gov, 301–451–0455. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Council of Council’s home page at http://

dpcpsi.nih.gov/council/ where an agenda 

will be posted before the meeting date. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 


khammond on DSKJM1Z7X2PROD with NOTICES